CollPlant Biotechnologies Ltd Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for CLGN, updated each market day.
CLGN AI Sentiment
AI predicts CollPlant Biotechnologies Ltd Ordinary Shares stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About CollPlant Biotechnologies Ltd Ordinary Shares
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
Exchange
Market Cap
$5,535,409
Cap Tier
Employees
39
Listed Since
June 4, 2021
Website
CLGN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CLGN Volatility
CollPlant Biotechnologies Ltd Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
